Sanjeev Balu

Summary

Publications

  1. ncbi Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review
    Sanjeev Balu
    Abbott Laboratories, Abbott Park, IL 60064 6145, USA
    Curr Med Res Opin 25:1329-41. 2009
  2. ncbi Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines
    Sanjeev Balu
    Abt Associates Inc, Lexington, Massachusetts, USA
    Clin Ther 31:1581-94. 2009
  3. ncbi Incremental treatment expenditure of diabetes in the United States
    Sanjeev Balu
    HERQuLES, Abt Associates, Inc, Lexington, Massachusetts 02421, USA
    Manag Care Interface 20:20-7. 2007
  4. ncbi Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence
    Sanjeev Balu
    Pharmaceutical Products Group, Abbott Laboratories, 200 Abbott Park Road, Abbott Park, IL 60064, USA
    Curr Med Res Opin 25:2765-75. 2009

Collaborators

Detail Information

Publications4

  1. ncbi Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review
    Sanjeev Balu
    Abbott Laboratories, Abbott Park, IL 60064 6145, USA
    Curr Med Res Opin 25:1329-41. 2009
    ....
  2. ncbi Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines
    Sanjeev Balu
    Abt Associates Inc, Lexington, Massachusetts, USA
    Clin Ther 31:1581-94. 2009
    ..Insufficient research about the economic impact of noncompliance with hypertension treatment guidelines has been published to date...
  3. ncbi Incremental treatment expenditure of diabetes in the United States
    Sanjeev Balu
    HERQuLES, Abt Associates, Inc, Lexington, Massachusetts 02421, USA
    Manag Care Interface 20:20-7. 2007
    ..Total incremental annual direct expenditures for patients with diabetes were estimated to be more than $82.0 billion in 2004. Diabetes expenditures represent a significant amount of health care resource utilization...
  4. ncbi Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence
    Sanjeev Balu
    Pharmaceutical Products Group, Abbott Laboratories, 200 Abbott Park Road, Abbott Park, IL 60064, USA
    Curr Med Res Opin 25:2765-75. 2009
    ....